Skip to main content

Table 2 Dose and schedule of anti-tuberculous drugs for the investigational group

From: Treatment shortening of drug-sensitive pulmonary tuberculosis using high-dose rifampicin for 3 months after culture conversion (Hi-DoRi-3): a study protocol for an open-label randomized clinical trial

Drug name

Dose (body weight)

Administration method

Isoniazid

300 mg/day

once a day before meal

Rifampicin

1200 mg/day (< 44 kg)

1500 mg/day (45–54 kg)

1800 mg/day (55–64 kg)

2100 mg/day (65–74 kg)

2400 mg/day (> 75 kg)

once a day before meal

Pyrazinamide

1000 mg/day (< 50 kg)

1500 mg/day (50–70 kg)

2000 mg/day (> 70 kg)

once a day after meal